Ticker
MTNBCompany Name
MATINAS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 11.42M | $ 6.53M | 57.12% |
3/31/2025 | $ 12.04M | $ 6.92M | 57.53% |
12/31/2024 | $ 12.64M | $ 7.28M | 57.62% |
9/30/2024 | $ 20.58M | $ 10.29M | 50.03% |
6/30/2024 | $ 24.36M | $ 4.22M | 17.3% |
3/31/2024 | $ 19.61M | $ 1.07M | 5.46% |
12/31/2023 | $ 25.1M | $ 4.79M | 19.07% |
9/30/2023 | $ 29.79M | $ 6.41M | 21.51% |
6/30/2023 | $ 34.02M | $ 9.74M | 28.63% |
3/31/2023 | $ 38.26M | $ 5.74M | 15% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for MATINAS BIOPHARMA HOLDINGS INC is calculated as follows: CashnEq [ $ 7.24M ] / Assets [ $ 74.81M ]
(=) Cash to Assets [ 9.67% ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |